Year: 2025
Type: article
Abstract: Yutaka Seino received honoraria for lectures from Sumitomo Pharma Co., Novo Nordisk Pharma Ltd, Taisho Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., and Mitsubishi Tanabe Pharma Corporation. Hitoshi Kuwata received grants from Ono Pharmaceutical Co., Taisho Pharmaceutical Co., and Novo Nordisk Pharma Ltd; and honoraria for lectures from Sanofi K.K., and Taisho Pharmaceutical Co. Yutaka Seino has received grants from Nippon Boehringer Ingelheim Co., Ltd, ARKRAY Marketing, Inc., Taisho Pharmaceutical Co., Ltd, Novo Nordisk Pharma Ltd, Terumo Corporation, and Sumitomo Pharma Co.; and honoraria for lectures from Taisho Pharmaceutical Co., Ltd, Nippon Becton Dickinson Company, Ltd, Novo Nordisk Pharma Ltd, Eli Lilly Japan K.K., Sumitomo Pharma Co., Ltd, and Ono Pharmaceutical Co., Ltd. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70218. All datasets presented in this manuscript are not publicly available but are available from the corresponding author on reasonable request. The resources are available on request.
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70218
Institutions: Kansai Electric Power (Japan), Kansai Electric Power Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415356341